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This paper reports the results of a population study designed to assess the standards of epilepsy care within a geographical 
population in relation to diagnosis, seizure management and quality of life. One of the findings was the unexpectedly high 
frequency of the misdiagnosis of epilepsy. Forty-nine of 214 patients with a primary diagnosis of epilepsy were subsequently 
found to have been misdiagnosed following a specialist review and investigations. All except two have been withdrawn from 
antiepileptic medication. The diagnosis of epilepsy was disputed in a further 26 patients. Of the 49 patients, 20 were found to 
have cardiovascular or cerebrovascular pathology. Seven had only ever experienced a single seizure and a further 10 were found 
to have underlying psychopathology. Such observations support the view that epilepsy is frequently misdiagnosed and this paper 
discusses some of the implications of misdiagnosis. 
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INTRODUCTION 
The diagnosis of epilepsy is essentially a clinical one 
and often complicated because of the variety of events 
which can resemble an epileptic seizure’y2. It has been 
estimated that approximately 20% of patients attending 
specialist epilepsy clinics do not have epilepsy3. 
This paper reports the results of a population study 
assessing the prevalence of epilepsy within a commu- 
nity and the burden of care for this condition. One of 
the findings was the unexpectedly high frequency of 
the misdiagnosis of epilepsy. 
MATERIALS AND METHODS 
In 1995 the CARE project was launched by The David 
Lewis Centre in partnership with a group of general 
practices, and with the support of the Department of 
Health. CARE stands for Community Awareness and 
Resources for Epilepsy. 
The purpose of the project was to audit the standards 
of epilepsy care within a geographical population in 
relation to diagnosis, seizure management and qual- 
ity of life. A new specialist epilepsy service was then 
initiated and the population surveyed after a year to 
*The CARE Project has been sponsored by the Department of 
Health, and supported by educational grants from Glaxo Wellcome, 
Parke Davis and Sanofi Winthrop. 
1059-131 ll96lO50403 + 04 $12.00/O 
identify any health gains (or otherwise) and impact on 
the burden of care. The project currently includes seven 
general practices ranging from a single-handed non- 
fundholding practice to a large total-purchasing fund- 
holding consortium. 
The practices involved in the project provided the 
names of all registered patients who had a diagnos- 
tic code for epilepsy. This sample was then cross- 
referenced against prescription information and discus- 
sions with the general practitioners. The sample was 
restricted to patients aged 5 years and over because of 
the frequently complicated nature of seizures and the 
underlying cerebral condition in very young children. 
All patients were initially informed by their prac- 
titioner of the new clinic to be held in the health 
centre. Following this initial postal contact, all pa- 
tients were then invited for a specialist consultation. 
The clinic was run by a consultant neuropsychia- 
trist and an epilepsy specialist nurse. If appropriate, 
electro-encephalography (EEG) was carried out in the 
clinic. Other investigations such as Magnetic Reso- 
nance Imaging (MRI) or head-up tilting were carried 
out in the nearby teaching hospital. 
The diagnosis of epilepsy was made by a consul- 
tant and experienced epileptologist. The diagnosis was 
based on clinical history, including response to medica- 
tion, seizure description and results of EEG investiga- 
tions, including videotelemetry and ambulatory moni- 
toring. 
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Table 1: Diagnosis in patients originally labelled as having 
epilepsy (n = 49). 
Diaanosis Number of uatients 
Cardiovascular cause 15 
Psychopathology 10 
One seizure only 7 
Alcohol-related 6 
Cerebrovascular cause 5 
Migraine 3 
Post-anaesthetic 2 
Eclampsia 1 
Where an alternative diagnosis was suspected, fur- 
ther investigations and referrals to other consultants 
were arranged. All patients were involved in the deci- 
sion regarding further investigation and management, 
with the principle of patient empowerment and choice 
a cornerstone of the specialist service*. 
RESULTS 
In a population of approximately 40 000 registered pa- 
tients, 261 were identified as having a primary diagno- 
sis of epilepsy and invited for review. This represents a 
prevalence of epilepsy of 0.65%. A number of patients 
identified by the practice had died or moved outside 
the catchment area and a few patients contacted the 
practices to decline any review. 
Forty-seven patients failed to attend (18%) although 
over time, a significant number have subsequently re- 
quested an appointment and been seen, although they 
are not yet included in this sample. 
Of the patients seen in the clinic, 49 (23.2%) were 
identified as not having epilepsy and all but two have 
since been withdrawn from antiepileptic medication. 
Of the two patients still taking antiepileptic drugs 
(AEDs), one remains on a small subtherapeutic dose, 
as she is unhappy to withdraw all medication after 40 
years on treatment, and the other is still in the process of 
drug withdrawal. Only patients who showed evidence 
of an alternative diagnosis, with no evidence to support 
the diagnosis of epilepsy and who were withdrawn from 
medication (other than the two cases mentioned) were 
considered to be cases of misdiagnosis. 
Table 1 gives a breakdown of the new diagnoses 
made. The significant points to draw from this table 
are that 20 of the 49 patients (9.3%) were found to 
have a cardiovascular or cerebrovascular condition, in- 
cluding: transient ischaemic episodes; vertebrobasilar 
insufficiency; postural hypotension; congenital heart 
disease; carotid sinus syndrome; sinus node disease 
and vasovagal syncope. Two patients have since be- 
come seizure-free following the insertion of a cardiac 
pacemaker and one is awaiting coronary angioplasty. 
Ten patients (4.7%) were found to have underlying 
psychopathology. The diagnoses included depression, 
generalized anxiety disorder, panic disorder and obses- 
sional compulsive disorder. Of this group, three were 
more extensively investigated and diagnosed as having 
non-epileptic attack disorder, with hysterical or disso- 
ciative disorder, factitious disorder and somatization 
disorder as the underlying aetiologies. 
Seven patients (3.3%) had only ever experienced a 
single seizure and by definition these patients do not 
suffer from epilepsy, since they have not experienced a 
‘recurrent’ seizure disorder. Two of these seven patients 
suffered a single seizure following cerebrovascular ac- 
cidents; the provoking factor in the other five patients 
included head injury, pre-eclampsia and following a 
general anaesthetic. 
In a further 26 cases, the diagnosis of epilepsy was 
disputed but for various reasons they have not yet been 
included. In some patients, further investigations are 
necessary, whilst others have decided to remain on a 
therapeutic dose of medication. Some patients in this 
group could possibly have both epilepsy and other 
nonepileptic seizures. 
In the 12 months prior to the new diagnosis being 
made, from the sample of 49 patients, nine required 
A&E attendance; four required hospital admission and 
the GP was called out after hours on one occasion. Ten 
patients had seen a specialist in the previous 12 months 
for their epilepsy, for a total of 17 visits. Nineteen of 
the 49 patients were on AEDs, including one on two 
drugs and one on three. Eleven of the 19 patients were 
on either phenytoin, phenobarbitone, or both, without 
regular monitoring or serum levels. 
DISCUSSION 
Many definitions of epilepsy exist but most would 
include the criteria that seizures are: spontaneous or 
unprovoked, recurrent (two or more), abnormal and 
excessive discharges of electrochemical activity in 
the brain resulting in clinical manifestations4. All of 
these criteria are considered essential to the diagnosis. 
Epilepsy cannot be diagnosed therefore on the basis of 
a single seizure since it is a recurrent seizure disorder. 
Similarly, drug or alcohol withdrawal seizures, seizures 
which occur during coma or following a head injury, 
or any other ‘non-spontaneous’ or provoked seizure, 
cannot be regarded as epilepsy. 
There are multiple causes of seizures and although 
epilepsy remains the most common, there appears to 
be little appreciation or understanding among clini- 
cians of other potentially life-threatening conditions 
which can present with seizures. It is sobering for ex- 
ample, to note the l-year mortality rates for people with 
syncope, a phenomenon often mistakenly diagnosed as 
epilepsy. It is reported that where a cardiac cause for 
syncope is found, the l-year mortality rate is between 
18% and 33%5-9 compared with 3-6% for syncope of 
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unknown origin”8. A significant number of patients 
are placed on antiepileptic medication, which may ex- 
acerbate the underlying condition or lead to debilitat- 
ing side-effects. Moreover, they frequently spend many 
years struggling with the psychosocial implications of 
the diagnosis of epilepsy. It is also not uncommon to 
find patients on large doses of AEDs whilst no prophy- 
laxis or preventative measures are taken to address the 
underlying condition. For example, patients who expe- 
rience seizures following a cerebral ischaemic event are 
placed on AEDs whilst their blood pressure is not ade- 
quately controlled and they have not considered taking 
non-steroidal drugs. 
Although hypoxia and head injuries during seizures 
can cause cerebral damage, there is little evidence 
that the seizure itself leads to a worsening of cere- 
bral function in the vast majority of cases. The un- 
derlying condition on the other hand, can occasionally 
be life-threatening, yet many clinicians appear to take 
the view that seizure control is of primary importance. 
The management of seizures is relatively simple if this 
is the therapeutic goal. Modified narcosis is, however, 
inappropriate in the majority of cases. The correct di- 
agnosis and appropriate management of the underlying 
condition giving rise to the seizure disorder, ought to be 
the primary therapeutic objective. The management of 
epilepsy also includes counselling and empowerment 
of the patient, enabling them to identify and manage or 
avoid factors which precipitate seizures*. 
In order to make an accurate diagnosis of epilepsy, 
sleep-deprived EEGs and ambulatory monitoring are 
useful tools, although not widely available or exten- 
sively used. These investigations are particularly im- 
portant where diagnostic doubts continue or the pa- 
tient remains refractory to treatment. Nevertheless, the 
diagnosis of epilepsy remains a clinical one, which is 
why the precise and detailed description of what occurs 
peri-ictally is essential and the experience and knowl- 
edge of the clinician remains the most important factor 
in determining diagnostic accuracy. 
It is significant that of the patients seen, possibly as 
many as 35% have been misdiagnosed as suffering from 
epilepsy. This does not include the 18% of patients who 
declined the offer of a review or failed to attend, and our 
experience is that a significant number declined a re- 
view because they felt they did not have epilepsy. Some 
of these patients will almost certainly also have been 
inappropriately labelled. If one assumes that the results 
of this survey are representative of the situation in the 
country as a whole (and there is no reason to suppose 
the contrary), then the implications are disconcerting 
to say the least. This is all the more worrying when one 
takes into account the fact that the population sampled 
was a skewed, wealthy middle-aged rural population 
with a relatively low prevalence of epilepsy. 
If these figures were replicated in a typical district 
with a population of 250000 we could expect to find 
that of 1750 patients 406 have been misdiagnosed with 
epilepsy (prevalence 0.7 per 1000). 
We have seen in this survey that in the 12 months 
prior to a new diagnosis being established, nine of the 
49 misdiagnosed patients attended A&E and a further 
four required hospital admission, with one other patient 
being seen by a GP out of the normal surgery hours be- 
cause of their ‘epilepsy’. Extrapolating the figures ob- 
served in this study to a typical district (population size, 
250 OOO), one could expect that 75 patients will attend 
A&E because of their seizures and 33 will require hos- 
pital admission. This suggests that patients who have 
been misdiagnosed are an inappropriate drain on ser- 
vices which are not meeting their needs. Furthermore, 
once a patient has been labelled as ‘epileptic’, clini- 
cians frequently fail to explore their condition further 
and little will have been gained in a therapeutic sense 
from the A&E attendance or hospital admission. The 
fact that an EEG is almost never performed in A&E or 
during an acute admission is testament to this fact. 
One further observation worthy of note concerns the 
AEDs that patients were on prior to the service being 
established. It is recognized that phenytoin and phe- 
nobarbitone no longer have a place as first-line treat- 
ment for epilepsy”. Despite this, 11 of the 19 patients 
on AEDs were on this medication (58%). The cost of 
maintaining almost 9% of patients with a diagnosis of 
epilepsy on medication inappropriately has many more 
implications than the cost of the tablets. 
In terms of an epidemiological study, the population 
sampled in this survey is relatively small. Despite this, 
we believe that the observations made are significant 
and if this survey has done nothing else, it has high- 
lighted the fact that epilepsy is frequently misdiagnosed 
at a substantial cost to both the patient and the Health 
Service. Given the high standard of healthcare in other 
disease areas and the increasing burden placed on the 
Health Service, this situation is unacceptable. Apart 
from the clinical and social ramifications of misdiag- 
nosis, the increasing trend for litigation places an added 
responsibility on the physician to establish an accurate 
diagnosis. The burden of care on the National Health 
Service in terms of hospital admissions, A&E atten- 
dances, etc. is also a worrying aspect. Although clini- 
cians cannot be expected to obtain a correct diagnosis 
every time, it is suggested that with greater care and 
improved understanding of epilepsy and other seizure 
conditions, diagnostic guidelines and protocols can be 
established which minimize the risk of misdiagnosis. 
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